Volume 2, Issue 4 (10-2017)                   hrjbaq 2017, 2(4): 217-224 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Malekzade M, Amani O, Peykani S. Comparative Study of Active Memory Capacity and Problem Solving Ability among Chemotherapy-Survived Women from Breast Cancer with Healthy Subjects. hrjbaq. 2017; 2 (4) :217-224
URL: http://hrjbaq.ir/article-1-145-en.html
Department of Psychology, Shahid Beheshti University, Tehran, Iran , (o.amani69@yahoo.com)
Abstract:   (4514 Views)

Introduction: The aim of this study was the evaluation of working memory capacity, planning and problem-solving ability in women survivors of breast cancer compare with healthy subjects.
Materials and Methods: In this causal-comparative study, women survivors of breast cancer with history of chemotherapy along with healthy women without any history of chronic diseases using available sampling method and were selected. Data were collected using demographic characteristics questionnaire, anxiety and depression tests; Tower of London (and N-Back tests. Finally data were analyzed by SPSS software via independent t test.
Results: The results were shown significant differences in all indicators of N-back (P=0.001) (average of correct answers and total test time) and the Tower of London test (number of movements (P=0.001), planning time (P=0.008) and thinking time (P=0.001)) in chemotherapy group compare with healthy subjects.
Conclusion: The results were indicated on problems in active memory and the ability to solving problem and planning among the survivals of breast cancer with a history of chemotherapy compared to non-affected counterparts. Due to the stability of effects of chemotherapy on brain functions, health professionals should follow-up side effect after treatment, in order to reduce these problems.

Full-Text [PDF 352 kb]   (1931 Downloads)    
Type of Study: Research | Subject: General
Received: 2017/04/9 | Revised: 2018/11/7 | Accepted: 2017/07/8 | ePublished ahead of print: 2017/10/5 | Published: 2017/10/5

1. Hajian S, Vakilian K, Najabadi KM, Hosseini J, Mirzaei HR. Effects of education based on the health belief model on screening behavior in high risk women for breast cancer, Tehran, Iran. Asian Pac J Cancer Prev. 2011;12(1):49-54.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012;62(1):10-29. [DOI:10.3322/caac.20138]
3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. International journal of cancer. 2001;94(2):153-6. [DOI:10.1002/ijc.1440]
4. Dashtbozorgi B, Husseini SM, Basak S, Latifi SM. The Influence of Massage Therapy on Common Complications in Breast Cancer Patient Undergoing Chemotherapy. 2012. Ahles TA, Saykin AJ. Breast cancer chemotherapy-related cognitive dysfunction. Clinical breast cancer. 2002;3:S84-S90.
5. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. The breast journal. 2007;13(4):383-91. [DOI:10.1111/j.1524-4741.2007.00446.x]
6. Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Critical reviews in oncology/hematology. 2007;63(3):183-202. [DOI:10.1016/j.critrevonc.2007.06.001]
7. Pinto AC, de Azambuja E. Improving quality of life after breast cancer: dealing with symptoms. Maturitas. 2011;70(4):343-8. [DOI:10.1016/j.maturitas.2011.09.008]
8. Smith IC, Heys SD, Hutcheon AW, Miller ID, Payne S, Gilbert FJ, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. Journal of Clinical Oncology. 2002;20(6):1456-66. [DOI:10.1200/JCO.2002.20.6.1456]
9. Simó M, Rifà-Ros X, Rodriguez-Fornells A, Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neuroscience & Biobehavioral Reviews. 2013;37(8):1311-21. [DOI:10.1016/j.neubiorev.2013.04.015]
10. Kane MJ, Engle RW. Working-memory capacity and the control of attention: the contributions of goal neglect, response competition, and task set to Stroop interference. Journal of experimental psychology: General. 2003;132(1):47. [DOI:10.1037/0096-3445.132.1.47]
11. Lazeron RH, Rombouts SA, Machielsen WC, Scheltens P, Witter MP, Uylings HB, et al. Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging. American Journal of Neuroradiology. 2000;21(8):1407-14.
12. Anderson P. Assessment and development of executive function (EF) during childhood. Child neuropsychology. 2002;8(2):71-82. [DOI:10.1076/chin.]
13. Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry. 2014;26(1):102-13. [DOI:10.3109/09540261.2013.864260]
14. Evens K, Eschiti VS. Cognitive Effects of Cancer Treatment:\" Chemo Brain\" Explained. Clinical Journal of Oncology Nursing. 2009;13(6). [DOI:10.1188/09.CJON.661-666]
15. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. Journal of Clinical Oncology. 2010;28(29):4434-40. [DOI:10.1200/JCO.2009.27.0827]
16. Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer treatment reviews. 2013;39(3):297-304. [DOI:10.1016/j.ctrv.2012.11.001]
17. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer. 2007;109(9):1905-13. [DOI:10.1002/cncr.22610]
18. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal study. The Breast. 2005;14(2):142-50. [DOI:10.1016/j.breast.2004.10.004]
19. Sahebi A, Asghari MJ, Salari RS. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. Iranian Psychologists. 2005;4(1):299-313.
20. Ajilchi B, Ahadi H, Nejati V, Delavar A. Executive Functions in Depressed and Non-depressed Individuals. Journal of Clinical Psycology. 2013;5(2):77-88.
21. Tehrani doost M AB, Sedigh A, Ashrafi M,Alaghband. Impaired executive function in patients with phenylketonuria treated. 2005;15:25-35.
22. Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho‐Oncology. 1995;4(1):61-6. [DOI:10.1002/pon.2960040108]
23. Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. Journal of the American Geriatrics Society. 2006;54(6):925-31. [DOI:10.1111/j.1532-5415.2006.00732.x]
24. Kohli S, Griggs JJ, Roscoe JA, Jean-Pierre P, Bole C, Mustian KM, et al. Self-reported cognitive impairment in patients with cancer. Journal of Oncology Practice. 2007;3(2):54-9. [DOI:10.1200/JOP.0722001]
25. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma. Cancer. 2004;100(11):2292-9. [DOI:10.1002/cncr.20272]
26. Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A. Cognitive effects of chemotherapy in breast cancer patients: a dose–response study. Psycho‐Oncology. 2013;22(7):1517-27. [DOI:10.1002/pon.3163]
27. Royall DR, Palmer R, Chiodo LK, Polk MJ. Declining executive control in normal aging predicts change in functional status: the Freedom House Study. Journal of the American Geriatrics Society. 2004;52(3):346-52. [DOI:10.1111/j.1532-5415.2004.52104.x]
28. Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33-50. [DOI:10.1016/j.cortex.2014.01.010]
29. Pomykala K, de Ruiter M, Deprez S, McDonald BC, Silverman D. Integrating imaging findings in evaluating the post-chemotherapy brain. Brain imaging and behavior. 2013;7(4):436-52. [DOI:10.1007/s11682-013-9239-y]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 CC BY-NC 4.0 | Health Research Journal

Designed & Developed by : Yektaweb